By clicking submit I agree to be contacted by Frank Leo via call, email, and text. To opt-out, you can reply 'stop' at any time or click the unsubscribe link in the emails. Message and data rates may apply.

    On Thursday, the vaccine that AstraZeneca and Oxford University are producing showed a robust immune response in older adults.

    The data published in the Lancet Medical Journal suggests that those that are over 70 years of age could potentially build robust immunity. 

    Maheshi Ramasamy, a consultant and co-lead investigator at the Oxford Vaccine Group, said, “The robust antibody and T-cell responses seen in older people in our study are encouraging.”

    Read more from the News Source HERE